Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-05

FDA Approved: LEVOTHYROXINE SODIUM — Original Application (Fosun Pharma USA Inc.)

View source ↗

Summary

FDA approves Fosun Pharma USA Inc.'s Levothyroxine Sodium anhydrous as a generic product under Original ANDA for thyroid hormone replacement in hypothyroid cond…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVOTHYROXINE SODIUM (levothyroxine sodium)

Snippet

ORIG AP for LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM ANHYDROUS)